Patent · US Active

Use of pharmaceutical compositions containing mesembrenone

US8552051B2 · kind B2 · utility

7Cited by

2References

19Claims

0Family size

Assignee

H. L. Hall & Sons Limited · CA

Inventors

Alan Harvey · Glasgow, GB
Nigel Peter GERICKE · Cape Town, ZA
Alvaro Viljoen · Randburg, ZA

Key dates

Filing date	Mar 16, 2010
Grant date	Oct 8, 2013
Priority date	—
Expiry date	Mar 16, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The use of mesembrenone and medicaments and dietary supplements containing mesembrenone. The applicant has surprisingly found that mesembrenone exhibits potent PDE-4 inhibition properties and, in addition to being useful in treating conditions that respond to treatment with a PDE-4 inhibitor, has dual activity on account of its serotonin-uptake inhibition properties. Mesembrenone is extracted and isolated, for example as a pure compound, from plant material of the plant family Mesembryanthemaceae. Preferably a plant or plants from the genus Sceletium, more preferably, Sceletium tortuosum(L) N.E.Br is used.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.